all glp 1 drugs New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks The ABC's of GLP-1s: Benefits,

What this means to me: This isnt just innovationits a shift in how we approach chronic diseases like diabetes and obesity

Additionally, 26.5% of participants receiving orlistat achieved at least a 5% reduction in BMI, compared to 15.7% in the placebo group

Indication bias (patients prescribed GLP-1 agonists may have underlying risk factors for autoimmune disease)

Control of gluconeogenesis in liver

Search items included medication-related itemsGLP-1 receptor agonist, GLP-1RA, dual-agonist, and glucagon-like peptide-1 along with cardiovascular outcome-related items major adverse cardiovascular event, myocardial infarction, coronary artery disease, peripheral arterial disease, heart failure, hypertension, and atrial fibrillation. Studies were meticulously screened and included if they reported cardiovascular outcomes related to MACE, myocardial infarction (MI), CAD, PAD, HF, hypertension (HTN), or AF

Week 1 at the starting dose The first injection often produces the most anxiety and the least actual effect